Skip to Content
PharmaceuticalsPharmaceuticals
  • Correction
  • Open Access

30 August 2024

Correction: Haddad et al. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171

,
and
1
BIOLIVAL Laboratory, LR14ES06, The Higher Institute of Biotechnology of Monastir ISBM, University of Monastir, Monastir 5000, Tunisia
2
Biochemistry Department, LR18ES47, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia
*
Author to whom correspondence should be addressed.
Removal of an Author
Alyne Rodrigues de Araujo requested to remove his name from the original publication [1] because he did not participate in the analysis of the original data presented in this paper. The corrected Author Contributions statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Author Contributions: This manuscript is the overall collaborative work of the participants. Writing, Methodology, Conceptualization, H.H.; Review-Validation, R.M.; Supervision, Review & Editing, A.Z. All authors have read and agreed to the published version of the manuscript.

Reference

  1. Haddad, H.; Mejri, R.; Zaïri, A. Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii. Pharmaceuticals 2024, 17, 171. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.